Raymond James Upgrades Acadia Healthcare (ACHC) to Strong Buy
Raymond James analyst John Ransom upgraded Acadia Healthcare (NASDAQ: ACHC) from Outperform to Strong Buy with a price target of $39.00 (from $25.00).
The analyst comments "We are upgrading Acadia to Strong Buy and raising our price target to $39 (14x 2028 FCF) from $25 following a solid 1Q beat and modest 2026 raise on both EBITDA and EPS (First Take here). Our upgrade is underscored by some additional analysis on both EBITDA and FCF from 2027-2030, as the company harvests its $200M target from underperforming facilities, along with modest (3%) underlying growth."
For an analyst ratings summary and ratings history on Acadia Healthcare click here. For more ratings news on Acadia Healthcare click here.
Shares of Acadia Healthcare closed at $27.85 yesterday.